160889-18-9

Basic information

• Product Name: Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate
• CAS NO: 160889-18-9
• Molecular Formula: C₁₇H₁₇BrO₄
• Molecular Weight: 365.22
• Mol File: 160889-18-9.mol

Chemical Properties

• CAS DataBase Reference: Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate(160889-18-9)
• EPA Substance Registry System: Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate(160889-18-9)

Safety Data

• Hazardous Substances Data: 160889-18-9(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate is used as a building block in organic synthesis for the creation of more complex molecules. Its diverse functional groups facilitate various chemical reactions, making it a versatile component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Biochemistry Research:
Due to its unique structure and functional groups, Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate is used in biochemical research to explore its potential interactions with biological systems. It may serve as a probe for understanding enzyme mechanisms, receptor binding, or as a precursor to bioactive molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate is used as a starting material for the development of new drugs. Its structural features may confer specific pharmacological properties, making it a candidate for further optimization and investigation as a potential therapeutic agent.
Used in Chemical Intermediates:
Methyl 2-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]benzoate is utilized as a chemical intermediate in the production of various specialty chemicals. Its ability to participate in a range of chemical transformations makes it valuable for the synthesis of dyes, fragrances, and other精细化工 products.

Upstream product

• 27475-14-5 2-benzyloxy-5-(2-bromoacetyl)benzoic acid methyl ester 
• 16475-90-4 estere metilico dell'acido 5-acetilsalicilico 
• 27475-09-8 5-acetyl-2-benzyloxybenzoic acid methyl ester 
• 100-44-7 benzyl chloride 

Downstream Products

• 94749-70-9 2-benzyloxy-5-(R)-oxiranylbenzoic acid methyl ester 
• 135271-47-5 (R)-(-)-salmeterol 
• 160889-19-0 2-Benzyloxy-5-((R)-2-{benzyl-[6-(4-phenyl-butoxy)-hexyl]-amino}-1-hydroxy-ethyl)-benzoic acid methyl ester 
• 960398-43-0 4-(2-(4-(4-(4-aminobutyl)phenyl)butylamino)-1-(R)-hydroxyethyl)-2-hydroxymethylphenol 
• 960398-42-9 (4-(4-(4-(2-(4-benzyloxy-3-hydroxymethylphenyl)-2-(R)-hydroxyethylamino)butyl)phenyl)butyl)carbamic acid benzyl ester 
• 960398-41-8 2-benzyloxy-5-(2-(4-(4-(4-benzyloxycarbonylaminobutyl)phenyl)butylamino)-1-(R)-hydroxyethyl)benzoic acid methyl ester 
• 960398-45-2 (4-(4-(4-(bis-(2-(4-hydroxy-3-hydroxymethylphenyl)-2-(R)-hydroxyethyl)amino)butyl)phenyl)butyl)amine 
• 960398-44-1 (4-(4-(4-(bis-(2-(4-benzyloxy-3-hydroxymethylphenyl)-2-(R)-hydroxyethyl)amino)butyl)phenyl)butyl)carbamic acid benzyl ester 

Relevant articles and documents

PHENYL SUBSTITUTED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS POSSESSING BETA AGONIST ACTIVITY

The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.

Enantioselective synthesis of salmeterol via asymmetric borane reduction

Enantioselective syntheses of both enantiomers of salmeterol are accomplished using asymmetric borane reductions with chiral oxazaborolidines as catalysts.